September 7 (SeeNews) - A consortium of Britain's Frontier Pharma Limited and Russian LLC NPA Petrovax Pharm could become the only remaining bidder in the tender for the purchase of a 25% state-owned stake in Serbia's drug maker Galenika, with India's Cadila Pharmaceutical expected to shortly withdraw its bid, Belgrade-based media reported.